Apotex Health

Apotex holds top-selling biosimilars and an oncology patient support program in Canada.

With high-quality over the counter and natural health products, Apotex is empowering consumers to take charge of their health and well-being.

Apotex supplies high-quality generic medicines and maintains a strong research and development pipeline to improve global access.

Apotex provides over 65 specialty and branded pharmaceuticals.

Apotex offers comprehensive healthcare resources, including patient education materials, instructional videos, and safety notices, to support healthcare professionals and patients.

Apotex provides patient educational resources, including counselling sheets and instructional videos, to help patients safely and effectively use their medications.

Access Apotex’s comprehensive healthcare resources, including patient educational materials, instructional videos, and safety advisories to support healthcare professionals and patients.

Access Apotex’s comprehensive healthcare resources, including patient education materials, instructional videos, and safety advisories to support healthcare professionals and patients.

Apotex shares news in Canada, including product updates, healthcare insights, industry developments, and company announcements for professionals and patients.

Apotex offers career opportunities in Canada, focusing on innovation, collaboration, and high-quality manufacturing to advance health.

Apotex hires for a global team dedicated to improving access to affordable, innovative medicines and health products.

Apotex provides career opportunities in Canada, emphasizing innovation, collaboration, and high-quality manufacturing to support health.

The leadership team at Apotex drives innovation and excellence in global healthcare.

Apotex’s executive leadership team guides the company, bringing pharmaceutical expertise and a shared vision for advancing access, innovation, and quality in global healthcare.

Apotex is advancing access to high-quality, cost-effective medicines through global scale, regulatory excellence, and purpose-driven innovation.

Apotex expands access to health worldwide and creates better health outcomes for everyone.

Apotex supplies high-quality products globally through research, manufacturing, and strategic partnerships.

Apotex aims for excellence, scalability, and efficiency in manufacturing safe, high-quality health products.

Email: [email protected] Fax: 1-866-429-9133 or 416-401-3819 Phone: 1-800-667-4708 or 416-401-7780 (follow prompts)

Find contact information for Apotex head office and worldwide or submit inquiries to specific teams.

Apotex empowers Canadian patients and healthcare providers with innovative, affordable medicines and solutions.

Apotex provides Canadian patients and healthcare professionals with innovative, affordable medicines and solutions.

Apotex expands access to affordable, quality medicines in Latin America through trusted Canadian innovation and regional manufacturing.

Apotex Health secures **CA$1.25 billion** through a senior unsecured notes offering. The company leverages debt financing to strengthen its capital structure amid growth initiatives. The funds support operations and potential expansion in its healthcare portfolio.

Oct 2026Yahoo FinanceNews article

APOTEX HEALTH CORP. launches its first senior unsecured notes offering, raising **$1.25 billion** in debt financing. The company uses proceeds to support operations and strategic initiatives outside the U.S. market. The announcement excludes distribution to U.S. news services.

Sep 2026AOL.comNews article

Apotex Health Corp. reports a **$38.3 million net loss** in its first quarter following its June public listing, as revenue declines compared to the same period last year. The company’s financial performance reflects challenges in generating profitability shortly after its initial public offering. No specific revenue figures or operational details are provided in the report.

Aug 2026Yahoo FinanceNews article

Apotex releases its first quarter Fiscal 2027 financial results on August 12, 2026, via a press release at 6:00 a.m. ET. The company follows up with a conference call and live webcast at 8:00 a.m. ET to discuss the performance. The event provides stakeholders with direct insights into Apotex’s operational and financial updates for the quarter.

Jul 2026BioSpaceNews article